Likewise, research by Madelene et al.,28 utilizing 5‐aza‐2'deoxycytidine (5‐aza‐dC) to reactivate p16 in Tu159 HNSCC cells, resulting in inhibited tumour growth, supports the functional implications of CDKN2A expression we observed. This evidence concerns the gene CDKN2A and neoplasm.